{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:02:34Z","timestamp":1788444154532,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":1847,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/annonc\/mdu104","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T23:51:45Z","timestamp":1394754705000},"page":"2134-2146","source":"Crossref","is-referenced-by-count":103,"title":["Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force"],"prefix":"10.1016","volume":"25","author":[{"given":"I.H.","family":"Kunkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Audisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Belkacemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Koper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Lagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Markouizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdu104_bb0010","series-title":"Cancer in the Elderly","first-page":"9","article-title":"Epidemiology of cancer","author":"Lamont","year":"1990"},{"key":"10.1093\/annonc\/mdu104_bb0015","article-title":"Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Sydney","author":"Delaney","year":"2003","journal-title":"Radiotherapy in Cancer Care: estimating optimal utilisation from a review of the evidence-based clinical Guidelines"},{"key":"10.1093\/annonc\/mdu104_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.coc.0000217824.20290.ab","article-title":"Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC)","volume":"29","author":"Firat","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1532-5415.1985.tb06313.x","article-title":"Relationship between age at diagnosis and treatment received by cancer patients","volume":"33","author":"Mor","year":"1985","journal-title":"J Am Geriatr Soc"},{"key":"10.1093\/annonc\/mdu104_bb0030","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1001\/jama.1986.03370240055036","article-title":"Choice of cancer therapy varies with age of patient","volume":"255","author":"Samet","year":"1986","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdu104_bb0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.semradonc.2006.04.005","article-title":"The clinical application of intensity-modulated radiation therapy","volume":"16","author":"Ten Haken","year":"2006","journal-title":"Semin Radiat Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000322414","article-title":"Technologies of image guidance and the development of advanced linear accelerator systems for radiotherapy","volume":"43","author":"Wu","year":"2011","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/PPO.0b013e3181d7e8b3","article-title":"Emerging role of radiotherapy in the management of liver metastases","volume":"16","author":"Swaminath","year":"2010","journal-title":"Cancer J"},{"key":"10.1093\/annonc\/mdu104_bb0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/COC.0b013e3180ca7cb1","article-title":"Stereotactic body radiation therapy: a comprehensive review","volume":"30","author":"Chang","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2011.08.027","article-title":"Development of an online adaptive solution to account for inter- and intra-fractional variations","volume":"100","author":"Li","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2010.03.014","article-title":"Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications","volume":"80","author":"Ahn","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2012.10.010","article-title":"Adaptive radiotherapy for head and neck cancer\u2014dosimetric results from a prospective clinical trial","volume":"106","author":"Schwartz","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0070","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.ijrobp.2009.10.013","article-title":"Online adaptive replanning method for prostate radiotherapy","volume":"77","author":"Ahunbay","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0075","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data on 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2011","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu104_bb0080","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/mdu104_bb0085","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0090","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardi-sation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu104_bb0095","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1158\/0008-5472.SABCS12-S4-1","article-title":"The UK START (Standardisation of Breast Radiotherapy) trials: 10-year follow-up results","volume":"72","author":"Haviland","year":"2012","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdu104_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu104_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radio-therapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu104_bb0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0120","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1200\/JCO.2006.06.5938","article-title":"Postmastectomy radiation and survival in older women with breast cancer","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","article-title":"MRC\/EORTC (BIG 2\u201304) SUPREMO Trial Management Group. Elucidating the role of chest wall irradiation in \u2018intermediate-risk\u2019 breast cancer: the MRC\/EORTC SUPREMO Trial","volume":"20","author":"Kunkler","year":"2008","journal-title":"Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2008.11.005","article-title":"Institut Curie Breast Cancer Study Group. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy","volume":"75","author":"Kirova","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0360-3016(00)00448-X","article-title":"Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis","volume":"47","author":"Grann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0140","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1200\/JCO.2007.12.5435","article-title":"Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database","volume":"25","author":"Owonikoko","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2008.01.008","article-title":"Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer","volume":"87","author":"Yu","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cncr.24759","article-title":"Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy","volume":"116","author":"Haasbeek","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cncr.22780","article-title":"North Central Cancer Treatment Group. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer","volume":"110","author":"Schild","year":"2007","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(02)00524-X","article-title":"Treatment of lung cancer in elderly part II: small cell lung cancer","volume":"40","author":"Weinmann","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.lungcan.2009.12.004","article-title":"Radiotherapy for lung cancer in the elderly","volume":"68","author":"Bayman","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/annonc\/mdm563","article-title":"Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome","volume":"19","author":"Thieblemont","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0180","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjc.6601675","article-title":"Long-term follow- up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma","volume":"90","author":"Spicer","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkins lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.2006.07.0722","article-title":"CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Bonnet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0195","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","article-title":"Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients","volume":"27","author":"Diepstra","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/annonc\/mdl379","article-title":"Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group","volume":"18","author":"Klimm","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0210","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0215","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/cncr.25751","article-title":"Overtreatment of men with low-risk prostate cancer and significant comorbidity","volume":"117","author":"Daskivich","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0220","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2009.06.038","article-title":"Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group","volume":"77","author":"Nguyen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0225","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1470-2045(11)70063-8","article-title":"Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial","volume":"12","author":"Denham","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0235","first-page":"30653","article-title":"Effects of short-term endocrine therapy prior to and during radiation therapy on overall survival in patients with T1b-T2b adenocarcinoma of the prostate and PSA equal to or less than 20: initial results of RTOG 94\u201308","author":"McGowan","year":"2010","journal-title":"Genitourinary Cancers Symposium (GUCS)"},{"key":"10.1093\/annonc\/mdu104_bb0240","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0245","first-page":"289","article-title":"Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial","volume":"299","author":"D'Amico","year":"2008","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdu104_bb0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2005.06.005","article-title":"Bicalutamide (\u2018Casodex\u2019) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme","volume":"76","author":"Tyrrell","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(98)05180-0","article-title":"Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial","volume":"353","author":"Dearnaley","year":"1999","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu104_bb0260","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2009.12.045","article-title":"Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer","volume":"79","author":"Arcangeli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.amjmed.2010.10.016","article-title":"Patterns and correlates of prostate cancer treatment in older men","volume":"124","author":"Roberts","year":"2011","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/mdu104_bb0270","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1200\/jco.2011.29.15_suppl.9001","article-title":"Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project","volume":"29","author":"Soubeyran","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0275","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0280","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0285","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2010.11.002","article-title":"Point: vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer","volume":"10","author":"Nout","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1093\/annonc\/mdu104_bb0295","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11912-011-0191-y","article-title":"The role of radiotherapy in endometrial cancer: current evidence and trends","volume":"13","author":"Creutzberg","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1093\/annonc\/mdu104_bb0300","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0305","first-page":"CD003916","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"4","author":"Kong","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mdu104_bb0310","unstructured":"Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer (PORTEC-3). ClinicalTrials.gov identifier: NCT00411138"},{"key":"10.1093\/annonc\/mdu104_bb0315","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","article-title":"Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated","volume":"86","author":"Chuong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1748-717X-8-240","article-title":"Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients","volume":"8","author":"Kim","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0325","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2010.04.003","article-title":"Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma","volume":"80","author":"Horowitz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0330","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s13566-012-0048-5","article-title":"Outcomes of definitive or preoperative IMRT chemoradiation for esophageal cancer","volume":"1","author":"Shridhar","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meddos.2006.12.003","article-title":"Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution","volume":"32","author":"Chen","year":"2007","journal-title":"Med Dosim"},{"key":"10.1093\/annonc\/mdu104_bb0345","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"Adjuvant therapy for patients with colon and rectal cancer","volume":"264","author":"NIH Consensus Conference","year":"1990","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdu104_bb0350","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0355","first-page":"541","article-title":"Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older","volume":"24","author":"Mantello","year":"2005","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1093\/annonc\/mdu104_bb0360","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ejso.2013.07.094","article-title":"Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older","volume":"39","author":"Maas","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0365","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(08)70129-3","article-title":"Controversies of total mesorectal excision for rectal cancer in elderly patients","volume":"9","author":"Rutten","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0370","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02104446","article-title":"Endocavitary irradiation in the conservative treatment of adenocarcinoma of the low rectum","volume":"16","author":"Papillon","year":"1992","journal-title":"World J Surg"},{"key":"10.1093\/annonc\/mdu104_bb0375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2004.10.010","article-title":"Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival","volume":"9","author":"Habr-Gama","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1093\/annonc\/mdu104_bb0380","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrclinonc.2011.75","article-title":"The role of local therapy in the management of lung and liver oligometastases","volume":"8","author":"Lo","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0385","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdu104_bb0390","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.20895","article-title":"Is older age associated with a worse rognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases","volume":"103","author":"Lutterbach","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jnci\/djq497","article-title":"DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma","volume":"103","author":"Christensen","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdu104_bb0400","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0405","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0410","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdu104_bb0415","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1002\/cncr.24406","article-title":"Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status","volume":"115","author":"Brandes","year":"2009","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdu104_bb0420","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","article-title":"Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial","volume":"13","author":"Wick","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0425","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstrom","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0430","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ijrobp.2005.04.037","article-title":"Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases","volume":"63","author":"Noel","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0435","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0440","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00405-010-1263-6","article-title":"Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS Congress in Vienna 2007","volume":"267","author":"Gr\u00e9nman","year":"2010","journal-title":"Eur Arch Otorhinolarygnol"},{"key":"10.1093\/annonc\/mdu104_bb0445","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2009.10.052","article-title":"Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study","volume":"79","author":"Huang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdu104_bb0450","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu104_bb0460","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijrobp.2009.04.061","article-title":"Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1\u20132 glottic cancer","volume":"77","author":"Rosenthal","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419367614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419367614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/11\/2134\/323597\/mdu104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T01:41:26Z","timestamp":1689039686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419367614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":91,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0923753419367614"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu104","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718310784.793502756","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718310784.793502416","asserted-by":"object"}]},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}